Filing Details

Accession Number:
0001493152-25-002850
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-01-17 19:00:06
Reporting Period:
2025-01-15
Accepted Time:
2025-01-17 19:00:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1795091 Os Therapies Inc OSTX Pharmaceutical Preparations (2834) 825118368
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2048828 Shalom Auerbach 15 Atlantic Avenue
Suite M2
Lynbrook NY 11563
No No Yes No
2048829 Einodmil Llc 396 Oakland Avenue
Cedarhurst NY 11516
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Disposition 2025-01-15 16,720 $6.74 2,531,211 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share 23,371 Direct
Footnotes
  1. The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
  2. The price reported in Column 4 is a weighted average price. These shares of Comm Stock were sold in multiple transactions at prices ranging from $6.618 to $6.80 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.